Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tze-Jou Yeh"'
Publikováno v:
F1000Research, Vol 7 (2018)
Background: Chikungunya virus (CHIKV) is a re-emerging pathogen that has caused widespread outbreaks affecting millions of people around the globe. Currently, there is no specific therapeutic drug against CHIKV, with symptomatic treatment only to man
Externí odkaz:
https://doaj.org/article/043764fa86dc40b18f7eb6b82de7f4ed
Publikováno v:
F1000Research
Background: Chikungunya virus (CHIKV) is a re-emerging pathogen that has caused widespread outbreaks affecting millions of people around the globe. Currently, there is no specific therapeutic drug against CHIKV, with symptomatic treatment only to man
Autor:
Sam Vasilevsky, Goutam Sen, Clifford M. Snapper, Quanyi Chen, Gouri Chattopadhyay, Jesus Colino, Tze-Jou Yeh
Publikováno v:
European Journal of Immunology. 38:3316-3326
TLR2(-/-) mice immunized with Streptococcus pneumoniae (Pn) elicit normal IgM, but defective CD4(+) T-cell-dependent type 1 IgG isotype production, associated with a largely intact innate immune response. We studied the T-cell-dependent phosphorylcho
Publikováno v:
British Journal of Haematology. 79:81-83
Any attempt to eradicate the heterogeneous cell population of a tumour mass would require the use of appropriate combination treatment protocols. The antitumour effects of interferon alpha (IFN alpha) in combination with AS2-1, the hydrolysis product
Publikováno v:
Journal of Medical Virology. 16:297-305
Immune-specific IFN (IFN) is produced by the peripheral blood mononuclear leukocytes (PBML) of greater than 95% of HSV-seropositive humans with infrequent recurrences of herpes labialis [Green, Yeh, and Overall, 1981]. However, herpes virus-induced i
Publikováno v:
The Journal of infectious diseases. 151(5)